Building Biotech Businesses - - BioPharm International


Building Biotech Businesses

BioPharm International

He continued, "The biotechnology industry is fast-moving, international, and highly dynamic. The Enterprise Ireland strategy is likewise dynamic, in line with the needs of biotech business developing in a fast-moving business and scientific environment."

Enterprise Ireland's Building Biotech Businesses strategy is clearly fulfilling its mission of helping grow and develop Ireland's entrepreneurial-led biotechnology and life sciences industries. Building Biotech Businesses will continue to encourage creation of new commercially focused biotech companies in Ireland, to nurture early-stage biotech companies, and to target foreign biotech entrepreneurs and early-stage companies with potential to locate in Ireland. It will also continue to fast-track biotech company development, and to encourage private-sector seed and venture capital in Ireland. The EI biotech team is now in place and is integrating its resources to deliver on the goals of this strategy — goals which, together with other progressive EI initiatives, will all play key roles in biotech sector development in Ireland now, and in years to come.

blog comments powered by Disqus



Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International,
Click here